Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia

✍ Scribed by J. Vela-Ojeda; M. García-Ruiz Esparza; A. Rosas-Cabral; Y. Padilla-González; J. García-Chávez; F. Tripp-Villanueva; E. Sánchez-Cortés; M. Ayala-Sánchez; L. García-León; L. Montiel-Cervantes; M. Rubio-Borja

• Publisher: Springer
• Year: 2002
• Tongue: English
• Weight: 62 KB
• Volume: 81
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-002-0480-5